An Observational Cohort Study to Assess the Risk of Autoimmune Diseases in Adolescent and Young Adult Women Aged 9 to 25 Years Exposed to Cervarix in the United Kingdom

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
Indications Cervical cancer; Human papillomavirus infections
Focus Adverse reactions
Sponsors GlaxoSmithKline; GSK

26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
05 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
05 Jun 2014 Trial status changed to active, no longer recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com